Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Alexander van Akkooi MD, PhD, FRACS
Alexander C. J. van Akkooi MD, PhD, FRACS Associate Editor
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
See All Experts
Published in Oncology and
1 other channel

Journal Scan / Research · August 27, 2022

Prognostic Value of Minimal Residual Disease in Patients With Classical Hodgkin Lymphoma Undergoing ASCT

Leukemia and Lymphoma

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Charles Gaulin MBBS

Leukemia and Lymphoma
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation
Leukemia and Lymphoma 2022 Aug 07;[EPub Ahead of Print], E Taranto, R Redd, E Jeter, K McHugh, JL Crombie, DC Fisher, E Jacobsen, CA Jacobson, AI Kim, AS LaCasce, OO Odejide, PB Dahi, Y Nieto, RM Joyce, YB Chen, KC Bonjoc, A Chaudhry, AF Herrera, P Armand, RW Merryman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated